Molecular characterization and clinical impact of human bocavirus at a tertiary hospital in Barcelona (Catalonia, Spain) during the 2014-2017 seasons.


Journal

Infection
ISSN: 1439-0973
Titre abrégé: Infection
Pays: Germany
ID NLM: 0365307

Informations de publication

Date de publication:
Aug 2023
Historique:
received: 31 08 2022
accepted: 06 11 2022
medline: 19 7 2023
pubmed: 20 11 2022
entrez: 19 11 2022
Statut: ppublish

Résumé

The aim was to describe the prevalence, molecular epidemiology and clinical manifestations of human bocavirus (HBoV) in patients attended at a tertiary hospital in Barcelona, Spain. From October 2014 to May 2017, respiratory specimens from paediatric patients were collected for respiratory viruses' laboratory-confirmation. Phylogenetic analyses from partial VP1 sequences were performed from all HBoV laboratory-confirmed specimens. Clinical features were retrospectively studied. 178/10271 cases were HBoV laboratory-confirmed. The median age was 1.53 (IQR 1.0-2.3). Co-detection was highly reported (136; 76%). All viruses belonged into HBoV1 genotype but one into HBoV2. Non-reported mutations were observed and two sites were suggestive to be under negative selection. 61% (109/178) cases had lower RTI (LRTI), of whom 84 had co-detections (77%) and 76 had comorbidities (70%). LRTI was the cause of hospitalization in 85 out of 109 cases (78%), and no differences were found regarding severity factors during hospitalization between co- and single-detections, except for median length of respiratory support, which was longer in cases with co-detections. Close monitoring of predominant HBoV1 showed a high similarity between viruses. The presence of comorbidities might explain the high prevalence of LRTI. Symptomatology in HBoV single-detected cases suggest that HBoV is a true pathogen.

Identifiants

pubmed: 36401674
doi: 10.1007/s15010-022-01955-z
pii: 10.1007/s15010-022-01955-z
pmc: PMC9676756
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

935-943

Subventions

Organisme : Instituto de Salud Carlos III
ID : REIPI RD16/0016/0003

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.

Références

Guido M, Tumolo MR, Verri T, Romano A, Serio F, De Giorgi M, et al. Human bocavirus: current knowledge and future challenges. World J Gastroenterol. 2016;22:8684.
doi: 10.3748/wjg.v22.i39.8684 pubmed: 27818586 pmcid: 5075545
Allander T, Tammi MT, Eriksson M, Bjerkner A, Tiveljung-Lindell A, Andersson B. Cloning of a human parvovirus by molecular screening of respiratory tract samples. Proc Natl Acad Sci USA. 2005;102:12891–6.
doi: 10.1073/pnas.0504666102 pubmed: 16118271 pmcid: 1200281
Cotmore SF, Agbandje-McKenna M, Chiorini JA, Gatherer D, Mukha D V, Pintel DJ, et al. Rationalization and extension of the taxonomy of the family Parvoviridae. ICTV. 2013. 1–18.
Kapoor A, Slikas E, Simmonds P, Chieochansin T, Shaukat S, Alam MM, et al. A new bocavirus species in human stool. J Infect Dis. 2009;199:196–200.
doi: 10.1086/595831 pubmed: 19072716
Pogka V, Moutousi A, Kossyvakis A, Kalliaropoulos A, Sgouras DN, Giannaki M, et al. Genetic variability of human metapneumo- and bocaviruses in children with respiratory tract infections. Influenza Other Respi Viruses. 2014;8:107–15.
doi: 10.1111/irv.12185
Kenmoe S, Vernet M-A, Njankouo-Ripa M, Penlap VB, Vabret A, Njouom R. Phylogenic analysis of human bocavirus detected in children with acute respiratory infection in Yaounde, Cameroon. BMC Res Notes BioMed Central. 2017;10:293.
doi: 10.1186/s13104-017-2620-y
Moesker FM, van Kampen JJA, van der Eijk AA, van Rossum AMC, de Hoog M, Schutten M, et al. Human bocavirus infection as a cause of severe acute respiratory tract infection in children. Clin Microbiol Infect Elsevier Ltd. 2015;21:964.e1-8.
doi: 10.1016/j.cmi.2015.06.014
Mietzsch M, Kailasan S, Garrison J, Ilyas M, Chipman P, Kantola K, et al. Structural insights into human bocaparvoviruses. J Virol. 2017;91.
Qiu J, Söderlund-Venermo M, Young NS. Human parvoviruses. Clin Microbiol Rev. 2017;30:43–113.
doi: 10.1128/CMR.00040-16 pubmed: 27806994
Jartti T, Hedman K, Jartti L, Ruuskanen O, Allander T, Söderlund-Venermo M. Human bocavirus—the first 5 years. Rev Med Virol. 2012;22:46–64.
doi: 10.1002/rmv.720 pubmed: 22038931
Martin ET, Fairchok MP, Kuypers J, Magaret A, Zerr DM, Wald A, et al. Frequent and prolonged shedding of bocavirus in young children attending daycare. J Infect Dis. 2010;201:1625–32.
doi: 10.1086/652405 pubmed: 20415535
Kapoor A, Simmonds P, Slikas B, Li L, Bodhidatta L, Sethabutr O, et al. Humn bocaviruses are highly diverse, dispersed, recombination prone, and prevalent enteric infections. J Infect Dis. 2010;201:1633–43.
doi: 10.1086/652416 pubmed: 20415538
Tamura K, Stecher G, Peterson D, Filipski A, Kumar S. MEGA6: molecular evolutionary genetics analysis version 6.0. Mol Biol Evol. 2013;30:2725–9.
doi: 10.1093/molbev/mst197 pubmed: 24132122 pmcid: 3840312
Glez-Peña D, Gómez-Blanco D, Reboiro-Jato M, Fdez-Riverola F, Posada D. ALTER: Program-oriented conversion of DNA and protein alignments. Nucleic Acids Res. 2010;38:14–8.
doi: 10.1093/nar/gkq321
Delport W, Poon AFY, Frost SDW, Kosakovsky Pond SL. Datamonkey 2010: a suite of phylogenetic analysis tools for evolutionary biology. Bioinformatics. 2010;26:2455–7.
doi: 10.1093/bioinformatics/btq429 pubmed: 20671151 pmcid: 2944195
Kosakovsky Pond SL, Frost SDWW. Not so different after all: a comparison of methods for detecting amino acid sites under selection. Mol Biol Evol. 2005;22:1208–22.
doi: 10.1093/molbev/msi105 pubmed: 15703242
Murrell B, Wertheim JO, Moola S, Weighill T, Scheffler K, Kosakovsky Pond SL. Detecting individual sites subject to episodic diversifying selection. Malik HS, editor. PLoS Genet. 2012;8:e1002764.
doi: 10.1371/journal.pgen.1002764 pubmed: 22807683 pmcid: 3395634
Dina J, Vabret A, Gouarin S, Petitjean J, Lecoq J, Brouard J, et al. Detection of human bocavirus in hospitalised children. J Paediatr Child Health. 2009;45:149–53.
doi: 10.1111/j.1440-1754.2008.01442.x pubmed: 19210599 pmcid: 7167115
Bastien N, Brandt K, Dust K, Ward D, Li Y. Human bocavirus infection. Canada Emerg Infect Dis. 2006;12:848–50.
doi: 10.3201/eid1205.051424 pubmed: 16704852
Shen J, Zhu Q, Zeng M, Yu H. Detection and genome analysis of human bocavirus 1–4 from hospitalized children with acute lower respiratory tract infection and symptoms of wheezing in Shanghai. Int J Mol Med. 2013;32:1415–20.
doi: 10.3892/ijmm.2013.1512 pubmed: 24085194
Kesebir D, Vazquez M, Weibel C, Shapiro ED, Ferguson D, Landry ML, et al. Human bocavirus infection in young children in the United States: molecular epidemiological profile and clinical characteristics of a newly emerging respiratory virus. J Infect Dis. 2006;194:1276–82.
doi: 10.1086/508213 pubmed: 17041854
Moreno B, Abrego L, Carrera J-P, Franco D, Gaitán M, Castillo J, et al. Detection of human bocavirus type 1 infection in Panamanian children with respiratory illness. J Med Virol. 2016;88:389–94.
doi: 10.1002/jmv.24346 pubmed: 26252655
Arnott A, Vong S, Rith S, Naughtin M, Ly S, Guillard B, et al. Human bocavirus amongst an all-ages population hospitalised with acute lower respiratory infections in Cambodia. Influenza Other Respi Viruses. 2013;7:201–10.
doi: 10.1111/j.1750-2659.2012.00369.x
Antón A, Marcos M, Torner N, Isanta R, Camps M, Martínez A, et al. Virological surveillance of influenza and other respiratory viruses during six consecutive seasons from 2006 to 2012 in Catalonia. Spain Clin Microbiol Infect Elsevier Ltd. 2016;22:1–9.
Schildgen O, Müller A, Allander T, Mackay IM, Völz S, Kupfer B, et al. Human bocavirus: passenger or pathogen in acute respiratory tract infections? Clin Microbiol Rev. 2008;21:291–304.
doi: 10.1128/CMR.00030-07 pubmed: 18400798 pmcid: 2292574
Streiter M, Malecki M, Prokop A, Schildgen V, Lüsebrink J, Guggemos A, et al. Does human bocavirus infection depend on helper viruses? A challenging case report. Virol J BioMed Central Ltd. 2011;8:417.
Wang Z, Deng X, Zou W, Engelhardt JF, Yan Z, Qiu J. Human bocavirus 1 is a novel helper for adeno-associated virus replication. J Virol. 2017;91:1–18.
doi: 10.1128/JVI.00710-17
Kalyanaraman N. In silico prediction of potential vaccine candidates on capsid protein of human bocavirus 1. Mol Immunol Elsevier. 2017;93:193–205.
doi: 10.1016/j.molimm.2017.11.024
Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, et al. The Protein Data Bank. Nucleic Acids Res. 2000;28:235–42.
doi: 10.1093/nar/28.1.235 pubmed: 10592235 pmcid: 102472
Williams JV. Déjà Vu All Over Again: Koch’s Postulates and Virology in the 21st Century. J Infect Dis. 2010;201:1611–4.
doi: 10.1086/652406 pubmed: 20415534
Andrés C, Vila J, Creus-Costa A, Piñana M, González-Sánchez A, Esperalba J, et al. Enterovirus D68 in Hospitalized Children, Barcelona, Spain, 2014–2021. Emerg Infect Dis [Internet]. 2022;28:1327–31. https://wwwnc.cdc.gov/eid/article/28/7/22-0264_article.htm
Piñana M, Vila J, Maldonado C, Galano-Frutos JJ, Valls M, Sancho J, et al. Insights into immune evasion of human metapneumovirus: novel 180- and 111-nucleotide duplications within viral G gene throughout 2014–2017 seasons in Barcelona. Spain J Clin Virol. 2020;132:104590.
doi: 10.1016/j.jcv.2020.104590 pubmed: 32957052

Auteurs

Maria Piñana (M)

Respiratory Viruses Unit, Virology Section, Microbiology Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, Passeig Vall d'Hebron 119-129, 08035, Barcelona, Spain.
CIBERINFEC, ISCIII-CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain.

Jorgina Vila (J)

Paediatric Hospitalization Unit, Department of Paediatrics, Hospital Universitari Maternoinfantil Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.

Cristina Andrés (C)

Respiratory Viruses Unit, Virology Section, Microbiology Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, Passeig Vall d'Hebron 119-129, 08035, Barcelona, Spain.
CIBERINFEC, ISCIII-CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain.

Jordi Saura (J)

Respiratory Viruses Unit, Virology Section, Microbiology Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, Passeig Vall d'Hebron 119-129, 08035, Barcelona, Spain.

Alejandra González-Sánchez (A)

Respiratory Viruses Unit, Virology Section, Microbiology Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, Passeig Vall d'Hebron 119-129, 08035, Barcelona, Spain.
CIBERINFEC, ISCIII-CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain.

Anna Creus-Costa (A)

Paediatric Hospitalization Unit, Department of Paediatrics, Hospital Universitari Maternoinfantil Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.

Narcís Saubi (N)

Respiratory Viruses Unit, Virology Section, Microbiology Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, Passeig Vall d'Hebron 119-129, 08035, Barcelona, Spain.
CIBERINFEC, ISCIII-CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain.

Juliana Esperalba (J)

Respiratory Viruses Unit, Virology Section, Microbiology Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, Passeig Vall d'Hebron 119-129, 08035, Barcelona, Spain.
CIBERINFEC, ISCIII-CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain.

Ariadna Rando (A)

Respiratory Viruses Unit, Virology Section, Microbiology Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, Passeig Vall d'Hebron 119-129, 08035, Barcelona, Spain.
CIBERINFEC, ISCIII-CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain.

Manuel Jesús Iglesias-Cabezas (MJ)

Respiratory Viruses Unit, Virology Section, Microbiology Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, Passeig Vall d'Hebron 119-129, 08035, Barcelona, Spain.
CIBERINFEC, ISCIII-CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain.

Josep Quer (J)

Liver Diseases-Viral Hepatitis, Liver Unit, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Hepáticas Y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain.

Antoni Soriano-Arandes (A)

Paediatric Hospitalization Unit, Department of Paediatrics, Hospital Universitari Maternoinfantil Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.

Pere Soler-Palacín (P)

Paediatric Hospitalization Unit, Department of Paediatrics, Hospital Universitari Maternoinfantil Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.

Tomàs Pumarola (T)

Respiratory Viruses Unit, Virology Section, Microbiology Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, Passeig Vall d'Hebron 119-129, 08035, Barcelona, Spain. virusrespiratoris@vallhebron.cat.
CIBERINFEC, ISCIII-CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain. virusrespiratoris@vallhebron.cat.

Andrés Antón (A)

Respiratory Viruses Unit, Virology Section, Microbiology Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, Passeig Vall d'Hebron 119-129, 08035, Barcelona, Spain. andres.anton@vallhebron.cat.
CIBERINFEC, ISCIII-CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain. andres.anton@vallhebron.cat.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH